div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentpfizer-limited-fachinformation-ibrance-75100125-mg-hartkapseln-november-2016htmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: · Pfizer Limited Fachinformation IBRANCE @ 75100125 mg Hartkapseln November 2016 1 2017-03-01 Nutzenbewertung-lQWiG Palbociclib-D-264-2pdf 2 Weide R Feiten S Friesenhahn loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220502135f5f814c66419b68952d7fd2html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentpfizer-limited-fachinformation-ibrance-75100125-mg-hartkapseln-november-2016htmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: · Pfizer Limited Fachinformation IBRANCE @ 75100125 mg Hartkapseln November 2016 1 2017-03-01 Nutzenbewertung-lQWiG Palbociclib-D-264-2pdf 2 Weide R Feiten S Friesenhahn loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220502135f5f814c66419b68952d7fd2html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentpfizer-limited-fachinformation-ibrance-75100125-mg-hartkapseln-november-2016htmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: · Pfizer Limited Fachinformation IBRANCE @ 75100125 mg Hartkapseln November 2016 1 2017-03-01 Nutzenbewertung-lQWiG Palbociclib-D-264-2pdf 2 Weide R Feiten S Friesenhahn loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...